BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 9916622)

  • 1. High-dose chemotherapy for salvage treatment of germ cell tumors: Charité, Virchow Klinikum, Berlin.
    Siegert W; Rick O; Beyer J
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S7-9. PubMed ID: 9916622
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.
    Beyer J; Rick O; Weinknecht S; Kingreen D; Lenz K; Siegert W
    Bone Marrow Transplant; 1997 Nov; 20(10):813-9. PubMed ID: 9404920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
    Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
    J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High dose chemotherapy with autologous stem cell support in the treatment of germ cell tumors: experience of the centre Léon-Bérard between 1982 and 1996].
    Fléchon A; Biron P; Philip I; Blay JY; Droz JP
    Bull Cancer; 1999 Apr; 86(4):391-9. PubMed ID: 10341344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose chemotherapy and ASCR of patients with relapsed or refractory germ cell tumors: long-term follow-up.
    Siegert W; Beyer J
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S60. PubMed ID: 8899176
    [No Abstract]   [Full Text] [Related]  

  • 6. Feasibility and usefulness of high-dose chemotherapy (high-dose ifosfamide, carboplatin and etoposide) combined with peripheral blood stem cell transplantation for male germ cell tumor: a single-institute experience.
    Hara I; Miyake H; Yamada Y; Yamanaka K; Furukawa J; Kumano M; Takenaka A; Fujisawa M
    Anticancer Drugs; 2006 Oct; 17(9):1057-66. PubMed ID: 17001179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential intermediate high-dose therapy with etoposide, ifosfamide and cisplatin for patients with germ cell tumors.
    Mardiak J; Fuchsberger P; Lakota J; Sálek T; Sycová-Milá Z; Drahokoupilová M; Baláz M; Koza I
    Neoplasma; 2000; 47(4):239-43. PubMed ID: 11043829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
    Bessho A; Ueoka H; Kiura K; Tabata M; Sunami K; Katayama Y; Yamane H; Hiraki A; Harada M
    Anticancer Res; 1999; 19(1B):693-8. PubMed ID: 10216478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation.
    Cronin S; Uberti JP; Ayash LJ; Raith C; Ratanatharathorn V
    Bone Marrow Transplant; 2000 Dec; 26(11):1247-9. PubMed ID: 11149742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [High-dose chemotherapy with peripheral blood stem cell autotransplantation for patients with poor-risk testicular germ cell tumors--pilot study of the Japan Blood Cell Transplantation Study Group].
    Nakagawa S; Miki T; Akaza H; Ozono S; Okano T; Sonoda Y; Tsukamoto T; Terachi T; Naito K; Naito S; Nishiyama T; Nonomura N; Hara I; Hoshi S; Yoshida O
    Hinyokika Kiyo; 1999 Nov; 45(11):805-9. PubMed ID: 10637748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy for germ cell tumors (GCT): Memorial Sloan Kettering Cancer Center.
    Motzer RJ
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S53-4. PubMed ID: 8899174
    [No Abstract]   [Full Text] [Related]  

  • 13. The ICE regimen (ifosfamide, carboplatin, etoposide) for the treatment of germ-cell tumors and metastatic trophoblastic disease.
    Lotz JP; André T; Bouleuc C; Péne F; Gattegno B; Bazelly B; Houry S; Chapiro J; Selle F; Gligorov J; Izrael V
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S55-9. PubMed ID: 8899175
    [No Abstract]   [Full Text] [Related]  

  • 14. Ifosfamide in the treatment of germ cell tumors.
    Nichols CR
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):65-73. PubMed ID: 8677452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
    Abali H; Urün Y; Oksüzoğlu B; Budakoğlu B; Yildirim N; Güler T; Ozet G; Zengin N
    Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early utilization of high-dose chemotherapy in germ cell tumors.
    Nichols CR
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S50-2. PubMed ID: 8899173
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
    Siegert W; Beyer J; Strohscheer I; Baurmann H; Oettle H; Zingsem J; Zimmermann R; Bokemeyer C; Schmoll HJ; Huhn D
    J Clin Oncol; 1994 Jun; 12(6):1223-31. PubMed ID: 7911158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor-risk testicular cancer and high-dose chemotherapy.
    Motzer RJ; Sheinfeld S
    J Clin Oncol; 2003 Nov; 21(22):4073-4. PubMed ID: 14568986
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
    Grodman H; Wolfe L; Kretschmar C
    Pediatr Blood Cancer; 2009 Jul; 53(1):33-6. PubMed ID: 19326417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?].
    Fléchon A; Droz JP
    Bull Cancer; 2001 Sep; 88(9):852-7. PubMed ID: 11604357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.